Pharmacologic treatment in diabetic macular edema

Zeshan A. Rana, P. Andrew Pearson

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Scopus citations


Diabetes mellitus is a group of metabolic diseases characterized by an increased blood glucose level secondary to defects in insulin secretion and/or action. According to the American Diabetes Association, as of 2002, the United States diabetes prevalence is 18.2 million people (6.3% of the population). Diabetics suffer from acute complications of the disease such as diabetic ketoacidosis and hyperosmolar nonketotic syndrome as well as chronic complications ranging from microvascular disease (nephropathy, neuropathy, retinopathy) to macrovascular disease (1).

Original languageEnglish
Title of host publicationIntraocular Drug Delivery
Number of pages10
ISBN (Electronic)9781420016505
StatePublished - Jan 1 2006

Bibliographical note

Publisher Copyright:
© 2006 by Taylor & Francis Group, LLC.

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Pharmacologic treatment in diabetic macular edema'. Together they form a unique fingerprint.

Cite this